Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML. [electronic resource]
Producer: 20150309Description: 234-42 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Aminoglycosides -- administration & dosage
- Amsacrine -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cladribine -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Gemtuzumab
- Humans
- Injections
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- drug therapy
- Liposomes
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Recurrence
- Remission Induction
- Risk Assessment
- Salvage Therapy -- methods
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.